Which Cancer Patients Benefit Most from Bisphosphonates?
Patients with bone metastases from cancers such as breast cancer, prostate cancer, and multiple myeloma benefit the most from bisphosphonates. These drugs are also beneficial for patients with cancers that cause high levels of calcium in the blood (hypercalcemia of malignancy).